Evidence map›Paper›PMID 34300070›Full record

ArticleInternational journal of environmental research and public health2021

The Oxygen Transport Triad in High-Altitude Pulmonary Edema: A Perspective from the High Andes.

Gustavo Zubieta-Calleja, Natalia Zubieta-DeUrioste

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Mechanisms Underlying Altitude-Induced and Group 3 Pulmonary Hypertension.International journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gustavo Zubieta-CallejaHigh Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana Prolongacion #55, La Paz 2826, Bolivia.ORCID 0000-0002-4283-6514
Natalia Zubieta-DeUriosteHigh Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana Prolongacion #55, La Paz 2826, Bolivia.ORCID 0000-0003-2675-5025

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute high-altitude illnesses are of great concern for physicians and people traveling to high altitude. Our recent article "Acute Mountain Sickness, High-Altitude Pulmonary Edema and High-Altitude Cerebral Edema, a View from the High Andes" was questioned by some sea-level high-altitude experts. As a result of this, we answer some observations and further explain our opinion on these diseases. High-Altitude Pulmonary Edema (HAPE) can be better understood through the Oxygen Transport Triad, which involves the pneumo-dynamic pump (ventilation), the hemo-dynamic pump (heart and circulation), and hemoglobin. The two pumps are the first physiologic response upon initial exposure to hypobaric hypoxia. Hemoglobin is the balancing energy-saving time-evolving equilibrating factor. The acid-base balance must be adequately interpreted using the high-altitude Van Slyke correction factors. Pulse-oximetry measurements during breath-holding at high altitude allow for the evaluation of high altitude diseases. The Tolerance to Hypoxia Formula shows that, paradoxically, the higher the altitude, the more tolerance to hypoxia. In order to survive, all organisms adapt physiologically and optimally to the high-altitude environment, and there cannot be any "loss of adaptation". A favorable evolution in HAPE and pulmonary hypertension can result from the oxygen treatment along with other measures.

Indexed as

Altitude SicknessHypertension, PulmonaryPulmonary EdemaAltitudeHumansHypoxiaOxygenOxygenacute sea-level sicknesscardiorespiratory testchronic hypobaric hypoxiahemoglobinhigh altitudehigh-altitude gas expansionhigh-altitude physiologylung diseaseoxygen contentphysiologic adaptationpulmonary hypertensiontolerance to hypoxiatravel to high-altitude cities

Identifiers

PMID34300070
PMCPMC8305285
OpenAlexW3184170613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.